The glycosaminoglycan-binding domain of PRELP acts as a cell type-specific NF-κB inhibitor that impairs osteoclastogenesis

Journal of Cell Biology

Volumn 187, Issue 5, 2009, Pages 669-683

  Rucci, Nadia ^a   Rufo, Anna ^a   Alamanou, Marina ^a   Capulli, Mattia ^a   Del Fattore, Andrea ^a   Åhrman, Emma ^b   Capece, Daria ^a   Iansante, Valeria ^a   Zazzeroni, Francesca ^a   Alesse, Edoardo ^a   Heinegård, Dick ^b   Teti, Anna ^a  

^a UNIVERSITY OF L'AQUILA   (Italy)

^b LUND UNIVERSITY   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

ALKALINE PHOSPHATASE; BINDING PROTEIN; CHONDROITIN SULFATE; GLYCOSAMINOGLYCAN; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; LIPOCORTIN 2; MITOGEN ACTIVATED PROTEIN KINASE; PROTEIN PRELP; UNCLASSIFIED DRUG; GLYCOPROTEIN; MEMBRANE PROTEIN; PRELP PROTEIN, MOUSE; PROTEOGLYCAN; SCLEROPROTEIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BONE REMODELING; CELL DIFFERENTIATION; CELL SURVIVAL; CONTROLLED STUDY; EPITHELIUM CELL; FEMALE; HISTOLOGY; INTERNALIZATION; MACROPHAGE; MOUSE; NONHUMAN; OSTEOBLAST; OSTEOCLAST; OVARIECTOMY; PRIORITY JOURNAL; PROTEIN DNA BINDING; PROTEIN DOMAIN; PROTEIN PROTEIN INTERACTION; RAT; SIGNAL TRANSDUCTION; TRANSCRIPTION REGULATION; ANIMAL; BINDING SITE; CHEMISTRY; DRUG ANTAGONISM; HUMAN; METABOLISM; OSTEOLYSIS; PHYSIOLOGY; PROTEIN TERTIARY STRUCTURE;

MUS;

ANIMALS; ANNEXIN A2; BINDING SITES; BONE RESORPTION; EXTRACELLULAR MATRIX PROTEINS; FEMALE; GLYCOPROTEINS; HUMANS; MEMBRANE PROTEINS; MICE; NF-KAPPA B; OSTEOCLASTS; PROTEIN STRUCTURE, TERTIARY; PROTEOGLYCANS; RATS; SIGNAL TRANSDUCTION;

EID: 74049094448     PISSN: 00219525     EISSN: 00219525     Source Type: Journal    
DOI: 10.1083/jcb.200906014     Document Type: Article

References (41)

1. Aguiar, D.J., W. Knudson, and C.B. Knudson. 1999. Internalization of the hyaluronan receptor CD44 by chondrocytes. Exp. Cell Res. 252:292-302. doi:10.1006/excr.1999.4641
2. Albini, A., Y. Iwamoto, H.K. Kleinman, G.R. Martin, S.A. Aaronson, J.M. Kozlowski, and R.N. McEwan. 1987. A rapid in vitro assay for quantitating the invasive potential of tumor cells. Cancer Res. 47:3239-3245.
3. Bengtsson, E. 1999. Structure and interactions of the extracellular matrix protein PRELP. PhD thesis. Lund University, S-221 00 Lund, Sweden. 163 pp.
4. Bengtsson, E., P.J. Neame, D. Heinegård, and Y. Sommarin. 1995. The primary structure of a basic leucine-rich repeat protein, PRELP, found in connective tissues. J. Biol. Chem. 270:25639-25644. doi:10.1074/jbc .270.43.25639
5. Bengtsson, E., A. Aspberg, D. Heinegård, Y. Sommarin, and D. Spillmann. 2000. The amino-terminal part of PRELP binds to heparin and heparan sulfate. J. Biol. Chem. 275:40695-40702. doi:10.1074/jbc.M007917200
6. Bengtsson, E., M. Mörgelin, T. Sasaki, R. Timpl, D. Heinegård, and A. Aspberg. 2002. The leucine-rich repeat protein PRELP binds perlecan and collagens and may function as a basement membrane anchor. J. Biol. Chem. 277:15061-15068. doi:10.1074/jbc.M108285200
7. Breckon, J.J., S. Papaioannou, L.W. Kon, A. Tumber, R.M. Hembry, G. Murphy, J.J. Reynolds, and M.C. Meikle. 1999. Stromelysin (MMP-3) synthesis is up-regulated in estrogen-deficient mouse osteoblasts in vivo and in vitro. J. Bone Miner. Res. 14:1880-1890. doi:10.1359/jbmr.1999.14.11.1880
8. Caselli, G., M. Mantovanini, C.A. Gandolfi, M. Allegretti, S. Fiorentino, L. Pellegrini, G. Melillo, R. Bertini, W. Sabbatini, R. Anacardio, et al. 1997. Tartronates: a new generation of drugs affecting bone metabolism. J. Bone Miner. Res. 12:972-981. doi:10.1359/jbmr.1997.12.6.972
9. Deepa, S.S., S. Yamada, M. Zako, O. Goldberger, and K. Sugahara. 2004. Chondroitin sulfate chains on syndecan-1 and syndecan-4 from normal murine mammary gland epithelial cells are structurally and functionally distinct and cooperate with heparan sulfate chains to bind growth factors. A novel function to control binding of midkine, pleiotrophin, and basic fibroblast growth factor. J. Biol. Chem. 279:37368-37376. doi:10.1074/ jbc.M403031200
10. El-Sayed, A., S. Futaki, and H. Harashima. 2009. Delivery of macromolecules using arginine-rich cell-penetrating peptides: ways to overcome endosomal entrapment. AAPS J. 11:13-22. doi:10.1208/s12248-008-9071-2
11. Franzoso, G., L. Carlson, L. Xing, L. Poljak, E.W. Shores, K.D. Brown, A. Leonardi, T. Tran, B.F. Boyce, and U. Siebenlist. 1997. Requirement for NF-kappaB in osteoclast and B-cell development. Genes Dev. 11:3482-3496. doi:10.1101/gad.11.24.3482
12. Futaki, S., T. Suzuki, W. Ohashi, T. Yagami, S. Tanaka, K. Ueda, and Y. Sugiura. 2001. Arginine-rich peptides. An abundant source of membrane-permeable peptides having potential as carriers for intracellular protein delivery. J. Biol. Chem. 276:5836-5840. doi:10.1074/jbc.M007540200
13. Futaki, S., I. Nakase, T. Suzuki, Z. Youjun, and Y. Sugiura. 2002. Translocation of branched-chain arginine peptides through cell membranes: flexibility in the spatial disposition of positive charges in membrane-permeable peptides. Biochemistry. 41:7925-7930. doi:10.1021/bi0256173
14. Futaki, S., I. Nakase, A. Tadokoro, T. Takeuchi, and A.T. Jones. 2007. Argininerich peptides and their internalization mechanisms. Biochem. Soc. Trans. 35:784-787. doi:10.1042/BST0350784
15. Gerke, V., C.E. Creutz, and S.E. Moss. 2005. Annexins: linking Ca2+ signalling to membrane dynamics. Nat. Rev. Mol. Cell Biol. 6:449-461. doi:10.1038/ nrm1661
16. Grover, J., E.R. Lee, L.C. Mounkes, C.L. Stewart, and P.J. Roughley. 2007. The consequence of PRELP overexpression on skin. Matrix Biol. 26:140-143. doi:10.1016/j.matbio.2006.10.005
17. Harder, T., R. Kellner, R.G. Parton, and J. Gruenberg. 1997. Specific release of membrane-bound annexin II and cortical cytoskeletal elements by sequestration of membrane cholesterol. Mol. Biol. Cell. 8:533-545.
18. Heinegård, D., A. Aspberg, A. Franzén, and P. Lorenzo. 2002. Glycosylated matrix proteins. In Connective Tissue and Its Heritable Disorders: Molecular, Genetic, and Medical Aspects. Second edition. P.M. Royce and B. Steinmann, editors. John Wiley & Sons Inc., New York. 271-291.
19. Hennekam, R.C. 2006. Hutchinson-Gilford progeria syndrome: review of the phenotype. Am. J. Med. Genet. A. 140:2603-2624.
20. Idris, A.I., A. Sophocleous, E. Landao-Bassonga, R.J. van't Hof, and S.H. Ralston. 2008. Regulation of bone mass, osteoclast function, and ovariectomy-induced bone loss by the type 2 cannabinoid receptor. Endocrinology. 149:5619-5626. doi:10.1210/en.2008-0150
21. Iozzo, R.V., and A.D. Murdoch. 1996. Proteoglycans of the extracellular environment: clues from the gene and protein side offer novel perspectives in molecular diversity and function. FASEB J. 10:598-614.
22. Jiang, H., R.S. Peterson, W. Wang, E. Bartnik, C.B. Knudson, and W. Knudson. 2002. A requirement for the CD44 cytoplasmic domain for hyaluronan binding, pericellular matrix assembly, and receptor-mediated endocytosis in COS-7 cells. J. Biol. Chem. 277:10531-10538. doi:10.1074/jbc .M108654200
23. Kania, J.R., T. Kehat-Stadler, and S.R. Kupfer. 1997. CD44 antibodies inhibit osteoclast formation. J. Bone Miner. Res. 12:1155-1164. doi:10.1359/ jbmr.1997.12.8.1155
24. Kosuge, M., T. Takeuchi, I. Nakase, A.T. Jones, and S. Futaki. 2008. Cellular internalization and distribution of arginine-rich peptides as a function of extracellular peptide concentration, serum, and plasma membrane associated proteoglycans. Bioconjug. Chem. 19:656-664. doi:10.1021/bc700289w
25. Lewis, M. 2003. PRELP, collagen, and a theory of Hutchinson-Gilford progeria. Ageing Res. Rev. 2:95-105. doi:10.1016/S1568-1637(02)00044-2
26. Li, Z., W.S. Hou, C.R. Escalante-Torres, B.D. Gelb, and D. Bromme. 2002. Collagenase activity of cathepsin K depends on complex formation with chondroitin sulfate. J. Biol. Chem. 277:28669-28676. doi:10.1074/jbc .M204004200
27. Li, J., E.Y. Liao, R.C. Dai, Q.Y. Wei, and X.H. Luo. 2004. Effects of 17 beta-estradiol on the expression of interstitial collagenases-8 and -13 (MMP-8 and MMP-13) and tissue inhibitor of metalloproteinase-1 (TIMP-1) in ovariectomized rat osteoblastic cells. J. Mol. Histol. 35:723-731. doi:10.1007/s10735-004-6206-3
28. Majava, M., P.N. Bishop, P. Hägg, P.G. Scott, A. Rice, C. Inglehearn, C.J. Hammond, T.D. Spector, L. Ala-Kokko, and M. Männikkö. 2007. Novel mutations in the small leucine-rich repeat protein/proteoglycan (SLRP) genes in high myopia. Hum. Mutat. 28:336-344. doi:10.1002/ humu.20444
29. Majumdar, M.K., P.S. Chockalingam, R.A. Bhat, R. Sheldon, C. Keohan, T. Blanchet, S. Glasson, and E.A. Morris. 2008. Immortalized mouse articular cartilage cell lines retain chondrocyte phenotype and respond to both anabolic factor BMP-2 and pro-inflammatory factor IL-1. J. Cell. Physiol. 215:68-76. doi:10.1002/jcp.21282
30. Marzia, M., N.A. Sims, S. Voit, S. Migliaccio, A. Taranta, S. Bernardini, T. Faraggiana, T. Yoneda, G.R. Mundy, B.F. Boyce, et al. 2000. Decreased c-Src expression enhances osteoblast differentiation and bone formation. J. Cell Biol. 151:311-320. doi:10.1083/jcb.151.2.311
31. Menaa, C., R.D. Devlin, S.V. Reddy, Y. Gazitt, S.J. Choi, and G.D. Roodman. 1999. Annexin II increases osteoclast formation by stimulating the proliferation of osteoclast precursors in human marrow cultures. J. Clin. Invest. 103:1605-1613. doi:10.1172/JCI6374
32. Nakamura, H., G. Sato, A. Hirata, and T. Yamamoto. 2004. Immunolocalization of matrix metalloproteinase-13 on bone surface under osteoclasts in rat tibia. Bone. 34:48-56. doi:10.1016/j.bone.2003.09.001
33. Nakano, K., Y. Okada, K. Saito, and Y. Tanaka. 2004. Induction of RANKL expression and osteoclast maturation by the binding of fibroblast growth factor 2 to heparan sulfate proteoglycan on rheumatoid synovial fibroblasts. Arthritis Rheum. 50:2450-2458. doi:10.1002/art.20367
34. Nakase, I., A. Tadokoro, N. Kawabata, T. Takeuchi, H. Katoh, K. Hiramoto, M. Negishi, M. Nomizu, Y. Sugiura, and S. Futaki. 2007. Interaction of arginine-rich peptides with membrane-associated proteoglycans is crucial for induction of actin organization and macropinocytosis. Biochemistry. 46:492-501. doi:10.1021/bi0612824
35. Nakase, I., T. Takeuchi, G. Tanaka, and S. Futaki. 2008. Methodological and cellular aspects that govern the internalization mechanisms of arginine-rich cell-penetrating peptides. Adv. Drug Deliv. Rev. 60:598-607. doi:10.1016/ j.addr.2007.10.006
36. Parfitt, A.M., M.K. Drezner, F.H. Glorieux, J.A. Kanis, H. Malluche, P.J. Meunier, S.M. Ott, and R.R. Recker. 1987. Bone histomorphometry: standardization of nomenclature, symbols, and units. Report of the ASBMR Histomorphometry Nomenclature Committee. J. Bone Miner. Res. 2:595-610.
37. Reardon, A.J., M. Le Goff, M.D. Briggs, D. McLeod, J.K. Sheehan, D.J. Thornton, and P.N. Bishop. 2000. Identification in vitreous and molecular cloning of opticin, a novel member of the family of leucine-rich repeat proteins of the extracellular matrix. J. Biol. Chem. 275:2123-2129. doi:10.1074/jbc.275.3.2123
38. Sterling, H., C. Saginario, and A. Vignery. 1998. CD44 occupancy prevents macrophage multinucleation. J. Cell Biol. 143:837-847. doi:10.1083/ jcb.143.3.837
39. Suzuki, K., B. Zhu, S.R. Rittling, D.T. Denhardt, H.A. Goldberg, C.A. McCulloch, and J. Sodek. 2002. Colocalization of intracellular osteopontin with CD44 is associated with migration, cell fusion, and resorption in osteoclasts. J. Bone Miner. Res. 17:1486-1497. doi:10.1359/jbmr.2002.17.8.1486
40. Teitelbaum, S.L., and F.P. Ross. 2003. Genetic regulation of osteoclast development and function. Nat. Rev. Genet. 4:638-649. doi:10.1038/nrg1122
41. Young, D.A., R.L. Lakey, C.J. Pennington, D. Jones, L. Kevorkian, D.R. Edwards, T.E. Cawston, and I.M. Clark. 2005. Histone deacetylase inhibitors modulate metalloproteinase gene expression in chondrocytes and block cartilage resorption. Arthritis Res. Ther. 7:R503-R512. doi:10.1186/ar1702